Fabio d'Amore

Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia

E. Sabattini, A. D. Dei Tos, V. Guzzardo, 2022, British journal of haematology.

Histology of the spleen in immune thrombocytopenia: clinical‐pathological characterization and prognostic implications

M. Fassan, E. Sabattini, A. D. Dei Tos, 2020, European journal of haematology.

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy.

R. Fanin, G. Pizzolo, M. Krampera, 2018, Leukemia research.

Thrombopoietin receptor agonists as second-line therapy in splenectomy-eligible persistent immune thrombocytopenia: a case series.

A. Lombardi, F. Vianello, G. Da Dalt, 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Accessory spleens recapitulate the immune microenvironment of the main spleen in immune thrombocytopenia.

A. D. Dei Tos, V. Guzzardo, F. Facchetti, 2023, British journal of haematology.

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

R. Latagliata, A. Cuneo, M. Krampera, 2020, British journal of haematology.